Advertisement

Picture Berlin Partner BIO 2024 International Convention San Diego 650x100px
Organisation › Details

Canopy Biosciences LLC

Canopy Biosciences was formed in 2016 and has rapidly built a comprehensive platform of products and services for gene editing, gene expression analysis and regulation, and bioprocessing. Canopy’s gene editing portfolio spans easy-to-use CRISPR kits, off-the-shelf cell lines, as well as full service custom cell line engineering. With the introduction of RareSeq, Canopy has added ultrasensitive DNA sequencing to its multi-omics platform including RNAseq, NanoString gene expression analysis, and multiplexed protein detection. Canopy Biosciences is headquartered in St. Louis, Missouri, and serves researchers at universities, research institutions and biotechnology and pharmaceutical companies worldwide. *

 

Period Start 2016-01-01 established
  Group Bruker (Group)
Products Industry BIOTECH
  Industry 2 genome editing (gene editing)
Person Person Weinstein, Edward (Canopy Biosciences 201904 CEO + Co-Founder)
     
Region Region St. Louis, MO
  Country United States (USA)
  Street 4320 Forest Park Avenue
The BioGenerator Labs
  City 63108 St. Louis, MO
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for »About Section«: Canopy Biosciences, LLC. (4/29/19). "Press Release: Canopy Biosciences Acquires Zellkraftwerk GmbH". St. Louis, MO.
     
   
Record changed: 2023-07-10

Advertisement

Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x200px

More documents for Bruker (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner BIO 2024 International Convention San Diego 650x300px




» top